Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares stood at 0.81 million during the latest session, with the company’s beta value hitting 1.42. At the last
In the latest trading session, 0.91 million Bioline Rx Ltd ADR (NASDAQ:BLRX) shares changed hands as the company’s beta touched 1.45. With the company’s most
Bioline Rx Ltd ADR (NASDAQ:BLRX) has a beta value of 1.42 and has seen 1.61 million shares traded in the last trading session. The company,
During the last session, Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares were 1.02 million, with the beta value of the company hitting 1.41. At the
During the last session, Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares were 1.52 million, with the beta value of the company hitting 1.42. The 52-week
In the last trading session, 1.24 million shares of the Bioline Rx Ltd ADR (NASDAQ:BLRX) were traded, and its beta was 1.41. Most recently the
In the last trading session, 1.4 million Bioline Rx Ltd ADR (NASDAQ:BLRX) shares changed hands as the company’s beta touched 1.39. With the company’s per
In last trading session, Bioline Rx Ltd ADR (NASDAQ:BLRX) saw 1.34 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share
Bioline Rx Ltd ADR (NASDAQ:BLRX) has a beta value of 1.40 and has seen 2.14 million shares traded in the last trading session. The company,
Bioline Rx Ltd ADR (NASDAQ:BLRX) has a beta value of 1.41 and has seen 6.63 million shares traded in the last trading session. The company,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
